Diurnal variations of neurokinin-1 receptor defines dosing time-dependent differences in antitumor effects of aprepitant in mice
Journal of Pharmacological Sciences · 2025
DOI: 10.1016/j.jphs.2025.04.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2025. Verfasst von Yoshihiro Seto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan. Electronic address:…. Hauptthemen laut MEDLINE: Aprepitant, Receptors, Neurokinin-1, Circadian Rhythm, Antineoplastic Agents. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aprepitant, a neurokinin-1 receptor (NK1R) antagonist, has the potential as a novel anticancer agent. This study explored the impact of chronotherapy on the antitumor effect of aprepitant in a mouse model of colorectal carcinoma. Aprepitant inhibited the proliferation of Colon-26 cells in vitro in a concentration-dependent manner and reduced the expression of cell cycle-related genes. Diurnal variations in NK1R mRNA and protein levels were observed in Colon-26 tumors, peaking at zeitgeber time (ZT) 2 and ZT 10, respectively. Administration of aprepitant at ZT 6, achieving peak plasma concentration at ZT 10, significantly reduced the tumor volume compared with administration at ZT 18. Despite the lower plasma concentrations and AUC0-12 h in the ZT 6 group, superior antitumor effect suggests a dosing time-dependent efficacy due to variations in NK1R expression rather than its pharmacokinetics. These findings indicate that the antitumor activity of aprepitant against colorectal cancer can be enhanced by aligning its administration with NK1R expression rhythms, warranting further exploration of aprepitant chronotherapy in cancer chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan. Electronic address: yoshseto@pha.u-toyama.ac.jp.
- Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan.
- Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan; Department of Drug Analysis, Daiichi University of Pharmacy, Fukuoka, Japan.
Zitieren
APA
Seto, Y., Tokeshi, S., Inoue, D., Okazaki, F., & To, H. (2025). Diurnal variations of neurokinin-1 receptor defines dosing time-dependent differences in antitumor effects of aprepitant in mice. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2025.04.007
Vancouver
Seto Y, Tokeshi S, Inoue D, Okazaki F, To H. Diurnal variations of neurokinin-1 receptor defines dosing time-dependent differences in antitumor effects of aprepitant in mice. Journal of Pharmacological Sciences. 2025. doi:10.1016/j.jphs.2025.04.007
BibTeX
@article{Seto2025,
author = {Seto, Yoshihiro and Tokeshi, Shun and Inoue, Daisuke and Okazaki, Fumiyasu and To, Hideto},
title = {Diurnal variations of neurokinin-1 receptor defines dosing time-dependent differences in antitumor effects of aprepitant in mice},
journal = {Journal of Pharmacological Sciences},
year = {2025},
doi = {10.1016/j.jphs.2025.04.007}
}
EUVIMED